Thursday, October 16, 2014 4:47:53 PM
1.Vancomycin is the drug of choice and is relatively cheap
2.Cubicin is a second line drug and needs 7 days
3. Now the infectious disease docs have Dalvance which is 2 doses separated by one week.
To really make B a "wonder" drug it absolutely must be non inferior to D at single day dosing.
The added benefit is that resistance should not be an issue.
This has not been proven clinically yet so for B to be a success it must be a one day dosing miracle.
I have committed to holding all shares because I believe B will satisfy this demand.
Please remember that at this time there are strict pharmacy guidelines for using antibiotics other then VANCOMYCIN for ABSSSI and most insurers will not pay for third line drugs, PERIOD.
It comes down to fiduciary as well as medical obligations thanks to OBAMACARE
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM